Jon Hudson, MEDTHINK COMMUNICATIONS
Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact.
Jon Hudson
VICE PRESIDENT OF MEDIA AND DIGITAL SERVICES | MEDTHINK COMMUNICATIONS
Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact. There's an immediate short term savings, but the long term ROI suffers because the lack of visibility may further depress sales and reduce market share. Consistency of messaging is lost during times of relative silence, and companies must spend extra to regain their presence in the market once the economy brightens.
Jon Hudson
In fact, recessions are a time to find great deals. Publishers are more aggressive with rates and offer better positions and integrated campaigns for less dollars. Competitors are likely pulling back on their advertising. There is less clutter and noise in the marketplace and more opportunity for your company to stand out and carve a niche for itself.
If the decision makers can't be convinced that recessions present an opportunity, then it's time to integrate new technology that creates efficiencies, and saves time and money.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
